First human trial tests new pill aimed at boosting cellular energy
Knowledge-focused
Recruiting now
This is a first-in-human study to test the safety and tolerability of a new oral drug called MIB-725. The study will enroll up to 32 healthy adults to receive a single dose of the drug at one of four increasing dose levels. The main goal is to see how the body handles the drug an…
Phase: PHASE1 • Sponsor: Metro International Biotech, LLC • Aim: Knowledge-focused
Last updated Apr 02, 2026 03:27 UTC